SinoMab BioScience Limited (HKG:3681)
Hong Kong · Delayed Price · Currency is HKD 1.210
+0.010 (0.83%)
Jun 18, 2026, 11:16 AM HKT
SinoMab BioScience Market Cap
SinoMab BioScience has a market cap or net worth of 1.66 billion as of June 17, 2026. Its market cap has increased by 27.01% in one year.
Market Cap
1.66B
Enterprise Value
1.62B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.21
Market Cap Chart
Since November 12, 2019, SinoMab BioScience's market cap has decreased from 6.04B to 1.66B, a decrease of -72.44%. That is a compound annual growth rate of -17.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 1.66B | -10.45% |
| Dec 31, 2025 | 1.86B | 56.14% |
| Dec 31, 2024 | 1.19B | -31.56% |
| Dec 29, 2023 | 1.74B | -7.18% |
| Dec 30, 2022 | 1.87B | -34.91% |
| Dec 31, 2021 | 2.88B | -37.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viva Biotech Holdings | 2.45B |
| Beijing Luzhu Biotechnology | 2.44B |
| AIM Vaccine | 2.40B |
| Antengene Corporation | 2.40B |
| Frontage Holdings | 2.03B |
| Clover Biopharmaceuticals | 1.99B |
| HighTide Therapeutics | 1.79B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.71B |